Dataset
Oxfendazole; LC-ESI-QTOF; MS2; CE: 20 eV; R=35000; [M+H]+
Chemical Information
| InChI | InChI=1S/C15H13N3O3S/c1-21-15(19)18-14-16-12-8-7-11(9-13(12)17-14)22(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,16,17,18,19) |
|---|---|
| SMILES | COC(=O)Nc1[nH]c2ccc(cc2n1)S(=O)c3ccccc3 |
| InChI Key | BEZZFPOZAYTVHN-UHFFFAOYSA-N |
| Molecular Formula | C15H13N3O3S |
| Exact Mass | 315.068 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by-sa/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Athens_Univ-AU106502 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2015-09-22 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| CB4105143 | ChemicalBook |
| DB11446 | DrugBank |
| 35812 | Rhea |
| 78352 | Brenda |
| MCULE-2247044354 | Mcule |
| 40854 | PubChem |
| PD000960 | ProbesDrugs |
| LSM-1466 | LINCS |
| 14899079 | PubChem: Thomson Pharma |
| SCHEMBL44121 | SureChEMBL |
| oxfendazole | Selleck |
| 16668179 | PubChem: Thomson Pharma |
| 53716-50-0 | ACToR |
| 5852394 | eMolecules |
| 902248 | eMolecules |
| 50300124 | BindingDB |
| OXFENDAZOLE | rxnorm |
| SYNANTHIC | rxnorm |
| RS-8858 | clinicaltrials |
| OXFENDAZOLE | clinicaltrials |
| J10.835I | Nikkaji |
| HY-B0291 | MedChemExpress |
| OMP2H17F9E | FDA SRS |
| DTXSID9044112 | EPA CompTox Dashboard |
| SYNANTHIC | clinicaltrials |
| 222691 | Brenda |
| HMDB0031812 | Human Metabolome Database |
| 22395238 | PubChem: Drugs of the Future |
| 35812 | ChEBI |
| CHEMBL42442 | ChEMBL |
| The data in this table is sourced from UniChem at EBI. | |